(NewMediaWire) - November 11, 2024 - DALLAS GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the ...
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback